Browse Data and Analysis

There have been no major changes to Malaysia's biotechnology regulations in the past year. The country continues to review its Biosafety Act, including how it will regulate gene edited products in the future. Malaysia currently has 61 genetically engineered (GE) products approved for import.

The revision of the Malaysia’s Biosafety Act 2007 and Biosecurity Regulations are on-going, with no anticipated timeframe for publication. In addition, the Department of Biosafety Malaysia conducted a public consultation on Low-Level Presence (LLP)...

Malaysia’s Biosafety Act 2007 and Biosecurity Regulations are currently under review by the Department of Biosafety. As of September 2022, 57 genetically engineered (GE) products have been approved for import, an increase of 14 percent from 2021.

The COVID 19 pandemic in Malaysia saw most government agencies operating at minimum staffing with most working from home throughout 2020 and 2021. This has severely impacted the number of GE events approved by the National Biosafety Board (NBB).

Malaysia currently does not have any domestic production of plant biotechnology.

Malaysia currently does not have any domestic production of plant biotechnology.

Malaysia currently does not have any domestic production of plant biotechnology.

On July 25, 2018, the Court of Justice of the European Union issued its judgment that organisms created through many newer genome editing techniques are to be regulated....

There have not been any significant developments since last year’s 2016 report....

A shifting political landscape in the EU has led to fears that voting “against” import authorization of Genetically Engineered (GE) crops is becoming perilously close to a new norm.

There have not been any significant developments to report since last year’s 2015 report...

There are no significant developments to report since the 2014 report...